Objective-- Vascular inflammation is a key feature of both micro- and macrovascular complications in diabetes. Several lines of evidence have implicated the cytokine tumor necrosis factor (TNF)alpha as an important mediator of inflammation in diabetes. In the present study we evaluated the role of TNFalpha in streptozotocin (STZ)-induced diabetes on vascular inflammation in C57BL/6 wild-type and apoE-/- mice. Methods and Results-- Diabetes increased the expression of vascular cell adhesion molecule (VCAM)-1 in cerebral arteries >150 microm in diameter as well as the macrophage accumulation in aortic root atherosclerotic plaques in apoE-/- mice. A more pronounced vascular inflammatory response was observed in diabetic TNFalpha-deficient apoE-/- mice. These mice were also characterized by increased accumulation of IgG and IgM autoantibodies in atherosclerotic lesions. Diabetes also increased VCAM-1 expression and plaque formation in apoE-competent TNFalpha-/- mice, whereas no such effects were observed in C57BL/6 wild-type mice. Conclusions-- The present findings suggest that TNFalpha does not mediate diabetic-induced vascular inflammation in mice and reveal an unexpected protective role for TNFalpha. These effects are partly attributable to a direct antiinflammatory role of TNFalpha, but may also reflect a defective development of the immune system in these mice. Using C57BL/6 wild-type and apoE-/- mice deficient for TNFalpha we demonstrate that TNFalpha does not mediate vascular inflammation in response to streptozotocin-induced hyperglycemia. We also report evidence for a dysregulation of vascular inflammation in TNFalpha-/- mice revealing an unexpected protective role for this cytokine. 10.1161/ATVBAHA.109.193862